Marshall Edwards Could Begin Phenoxodiol Pivotal Trial Enrollment Next Month
This article was originally published in The Pink Sheet Daily
Executive Summary
Study of the investigational cancer drug will evaluate its ability to restore sensitivity of ovarian cancers to carboplatin.